Zhejiang Huahai Pharmaceutical Co., Ltd.
600521
Rangering i aksjer
#4354
Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical... Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical enterprise with a global presence. Its diverse portfolio encompasses treatments for central nervous system disorders, cardiovascular conditions, and viral infections, among other finished pharmaceutical products. Beyond finished drugs, the company also produces Active Pharmaceutical Ingredients (APIs) and crucial intermediates. Huahai Pharmaceutical further engages in the manufacturing of packaging components, notably high-density polyethylene (HDPE) bottles and polypropylene (PP) caps. Additionally, it offers contract manufacturing (CMO) and other specialized services, while also playing a role in import and export trade services. Established in 1989, the company maintains its headquarters in Linhai, China.
Aksjekurs
$2.41
Markedsverdi
$3.61B
Endring (1 dag)
-0.60%
Endring (1 år)
-10.36%
Land
CN
Handel Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
Kategori
Healthcare
P/B-forhold for Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
P/B-forhold per October 2026 TTM: 2.51
Ifølge Zhejiang Huahai Pharmaceutical Co., Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 2.51. Ved slutten av 2023 hadde selskapet et P/B-forhold på 2.65.
P/B-historikk for Zhejiang Huahai Pharmaceutical Co., Ltd. fra 2000 til 2026
P/B-forhold ved hvert års slutt
| År | P/B-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 2.51 | -13.88% |
| 2024 | 2.92 | 10.29% |
| 2023 | 2.65 | -36.78% |
| 2022 | 4.19 | -12.79% |
| 2021 | 4.80 | -36.36% |
| 2020 | 7.54 | 85.37% |
| 2019 | 4.07 | 32.50% |
| 2018 | 3.07 | -52.04% |
| 2017 | 6.40 | 24.40% |
| 2016 | 5.15 | -7.28% |
| 2015 | 5.55 | 57.53% |
| 2014 | 3.52 | 4.58% |
| 2013 | 3.37 | 6.18% |
| 2012 | 3.17 | -18.62% |
| 2011 | 3.90 | -27.34% |
| 2010 | 5.37 | -17.31% |
| 2009 | 6.49 | 93.63% |
| 2008 | 3.35 | -49.89% |
| 2007 | 6.69 | 83.20% |
| 2006 | 3.65 | 42.68% |
| 2005 | 2.56 | -17.88% |
| 2004 | 3.12 | 42.37% |
| 2003 | 2.19 | -88.84% |
| 2002 | 19.61 | -10.48% |
| 2001 | 21.91 | -10.48% |
| 2000 | 24.48 | 0.00% |
P/B-forhold for lignende selskaper eller konkurrenter
| Selskap | P/B-forhold | Forskjell i P/B-forhold | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 100.47% |
IN
|
